# Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

> **NCT01821833** · NA · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 60 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Neoplasm
- Pain

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 fatty acid
- **DIETARY_SUPPLEMENT:** Placebo
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01821833
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-24
- **Primary completion:** 2018-01-16
- **Final completion:** 2022-08-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01821833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01821833, "Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01821833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*